Formats
  1. Journal Article (67678)
  2. Meeting Abstract (34145)
  3. Book Section (5156)
  4. Review (3962)
  5. Editorial (2310)
  6. Conference Paper (1529)
  7. Guidelines (705)
  8. Correspondence (696)
  9. Research Letter (577)
  10. Miscellaneous (363)
  11. Book Whole (348)
Groups
  1. Department of Medicine (39735)
  2. GSK Faculty (22753)
  3. Solid Tumor Oncology Division (22407)
  4. Surgery (21574)
  5. Survivorship Research (16029)
  6. Sloan Kettering Institute Faculty (15770)

More Groups

People
  1. Marc Ladanyi (1336)
  2. Robert Motzer (1252)
  3. Victor Reuter (1234)
  4. Howard Scher (1133)
  5. Sergio Giralt (1069)
  6. Murray Brennan (1060)

More People

Years
  1. 2026 (12)
  2. 2025 (3709)
  3. 2024 (5629)
  4. 2023 (5810)
  5. 2022 (6175)
  6. 2021 (5725)

More Years

Publications
  1. Journal of Clinical Oncology (8712)
  2. Blood (5175)
  3. Cancer Research (2705)
  4. International Journal of Radiation Oncology, Biology, Physics (2628)
  5. Laboratory Investigation (1890)
  6. Modern Pathology (1818)

More Publications

Publishers
  1. Elsevier Inc. (12839)
  2. American Society of Clinical Oncology (9323)
  3. Springer (7307)
  4. Nature Publishing Group (6499)
  5. American Association for Cancer Research (6057)
  6. Elsevier Science, Inc. (5578)

More Publishers

Results (117469)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Feasibility of 2-hydroxyglutarate 1H-MR spectroscopy for routine clinical glioma imaging
    Meeting Abstract

    de la Fuente, M. I.; Young, R.; Rubel, J.; Tisnado, J.; Briggs, S.; Holodny, A. I.; Deasy, J.; DeAngelis, L. M.; Cross, J.; Mellinghoff, I. K.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Analysis of cell-free tumor DNA in cerebrospinal fluid to characterize and monitor the genetic alterations of brain tumors
    Meeting Abstract

    De Mattos-Arruda, L.; Mayor, R.; Ng, C. K. Y.; Weigelt, B.; Martinez-Ricarte, F.; Torrejon, D.; Oliveira, M.; Raventos, C.; Arias, A.; Guerini-Rocco, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Deleterious alterations in DNA damage response genes are associated with improved outcome in muscle-invasive bladder cancer patients treated with radiation-based bladder preservation
    Meeting Abstract

    Desai, N. B.; Iyer, G.; Cha, E. K.; Scott, S. N.; Hreiki, J.; Sfakianos, J. P.; Kim, P.; Bagroida, A.; Bochner, B. H.; Rosenberg, J. E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Distrust and conflict in sickle cell disease: Intersecting narratives of patients and physicians
    Meeting Abstract

    Tsyvkin, E.; Riessman, C.; Mathew, P.
    Blood (2015)

    Fulltext@MSK | Save
  • Success of online curriculum-based education in the management of multiple myeloma and continuing gaps among hematologists/oncologists
    Meeting Abstract

    Van Laar, E. S.; Landgren, O.
    Blood (2015)

    Fulltext@MSK | Save
  • Phase 1 study of CB-839, a first-in-class, glutaminase inhibitor in patients with multiple myeloma and lymphoma
    Meeting Abstract

    Vogl, D. T.; Younes, A.; Stewart, K.; Orford, K. W.; Bennett, M.; Siegel, D.; Berdeja, J. G.
    Blood (2015)

    Fulltext@MSK | Save
  • SH2B3/LNK loss of function promotes atherosclerosis and thrombosis
    Meeting Abstract

    Wang, W.; Tang, Y.; Wang, Y.; Balcerek, J.; Tong, W.; Levine, R. L.; Welch, C.; Tall, A.; Wang, N.
    Blood (2015)

    Fulltext@MSK | Save
  • Refractory T-cell prolymphocytic leukemia with JAK3 mutation: In vitro and clinical synergy of tofacitinib and ruxolitinib
    Meeting Abstract

    Wei, M.; Koshy, N.; van Besien, K.; Inghirami, G.; Horwitz, S. M.
    Blood (2015)

    Fulltext@MSK | Save
  • The finding of Del 17p in marrow plasma cells from patients with light-chain amyloidosis (AL) may confer a worse prognosis
    Meeting Abstract

    Wong, S. W.; Palladini, G.; Hegenbart, U.; Landau, H.; Warner, M.; Jaccard, A.; Avet-Loiseau, H.; Hansen, T.; Blade, J.; Cibeira, M. T.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Phase 1b study of PD-1 blockade with pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma (PMBCL)
    Meeting Abstract

    Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Snyder, E.; Marinello, P.; Shipp, M. A.; Armand, P.
    Blood (2015)

    Fulltext@MSK | Save